Frederick Researcher Speaks on New Arthritis Therapy in Philadelphia

Frederick, MD (PressExposure) October 17, 2008 -- "Up until 15 years ago, the best we could hope for with rheumatoid arthritis was to help our patients with their pain and maybe slow down the disease a bit. We've come a long way and now we have drugs that hone in on the abnormalities that we know cause much of the immune-related damage and destruction. These drugs act with laser-like precision. The medicine I was discussing is a new type of drug that has been bio-engineered to act more quickly and stays around in the inflamed joints longer than current drugs," said Dr. Nathan Wei.

Dr. Wei states, "It is now possible- in fact almost probable- if we get to a patient with rheumatoid arthritis soon enough- that we can get them into remission. A cure is certainly within the realm of possibility," adds Dr. Wei.

"We are also getting a better handle on balancing risks versus side-effects, obviously a critical area that must be mastered," concludes Dr. Wei.

Rheumatoid arthritis is a chronic, systemic, autoimmune disease. It is the most common inflammatory form of arthritis and affects approximately 2.1 million Americans.

About Arthritis and Osteoporosis Center of Maryland

Dr. Wei is a board-certified rheumatologist and is director of the research program at the Arthritis and Osteoporosis Center of Maryland, a nationally recognized arthritis research center, located in Frederick, Maryland.

Press Release Source:

Press Release Submitted On: October 17, 2008 at 10:38 am
This article has been viewed 21302 time(s).